Aviir discovers, develops and commercializes diagnostic laboratory tests employing the latest technologies with a focus on cardiovascular disease along with related metabolic disorders. Beyond these novel tests, an extensive menu of standard of care cardiovascular & metabolic tests are provided through the company's CLIA certified laboratory. Aviir's MIRISK and MIRISK VP assessments objectively identify, using a single blood draw, individuals who are at a high risk of experiencing a cardiac event over the next five years.
Latest Aviir News
Jun 22, 2013
Timothy Hay, (c) 2013 Dow Jones & Company, Inc. (c) 2013 Dow Jones & Company, Inc. Cardiovascular diagnostic company Aviir Inc . has raised a first equity round after reaching milestones and opening up a laboratory in Southern California--a lab that is now seeing brisk business--the company said. Founded in 2005, the company raised several previous rounds, including bridge financings, that have now converted to equity, bringing its total Series B round to $30 million, Chief Executive Douglas Harrington said.... Document DJFVW00020130621e96lruov3
Aviir Frequently Asked Questions (FAQ)
When was Aviir founded?
Aviir was founded in 2005.
Where is Aviir's headquarters?
Aviir's headquarters is located at 9805 Research Drive, Irvine.
What is Aviir's latest funding round?
Aviir's latest funding round is Series D - III.
How much did Aviir raise?
Aviir raised a total of $65.19M.
Who are the investors of Aviir?
Investors of Aviir include Aberdare Ventures, Bay City Capital, New Leaf Venture Partners, Merck Global Health Innovation Fund, Partners & Partners and 4 more.
Who are Aviir's competitors?
Competitors of Aviir include Life Line Screening, Linkage Biosciences, VitaPath Genetics, Navigenics, MicroPhage and 9 more.
Compare Aviir to Competitors
Genera Biosystems is a development phase company that designs, develops and produces and clinically effective human molecular diagnostics with a focus on women's health.
Integrative Diagnostics is a early cancer detection company founded by Leroy Hood.
Helix Diagnostics LLC is pursuing development and commercialization of multiplexed DNA detection systems based on capillary electrophoresis.
Columbia BioSystems Inc. is a company engaged in molecular Nano-diagnostics using Molecularly Imprinted Polymers (MIPs) for the rapid detection of pathogens such as Methicillin-resistant Staphylococcus aureus (MRSA) , Anthrax, HIV, and Trypanosomiasis (sleeping sickness). The company uses MIPs to bind to proteins and, upon binding, change color thereby signaling the presence of the bacteria, virus or parasite.
3PrimiR is researching how mutations in micro RNA molecules can be used in cancer diagnostics.
Life Line Screening offers preventive health screening services for stroke, abdominal aortic aneurysm, peripheral arterial disease, diabetes, heart disease & osteoporosis.